AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASSEMBLY BIOSCIENCES, INC. Director's Dealing 2021

May 24, 2021

33081_dirs_2021-05-24_c8030239-ace3-42c3-afef-f7bc8eeb82e0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2021-05-20

Reporting Person: Johnson-Pratt Lisa (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-20	Stock Option (right to buy)	$4.03	A	30000	Acquired	2031-05-20	Common Stock (30000)	Direct

Footnotes

F1: Grant of stock options. The stock options vest in three equal installments, assuming continuous service on each vesting date, as follows: May 20, 2022; May 20, 2023; and May 20, 2024.